🔎 Spotted in @pubs.acs.org Biomaterials Science & Engineering!
Researchers from the Institute for Stem Cell Science and Regenerative Medicine, among others, used 3 of our MYHC mAbs [MF20, SC-71, A4.951] in a study on how NRH affects engineered human skeletal muscle differentiation and maturation.
🔎 Spotted in Journal of Cellular Biochemistry by @wileyonlinelibrary.bsky.social!
Researchers at @uspoficial.bsky.social used our anti-osteopontin [MPIIIB10(1)] mAb in a new study showing that agrin supports bone formation and may be a promising therapeutic target for bone loss–related conditions.
🔎 Spotted in @jci.org!
Researchers at the University of Osaka, among others, used our anti-MHC [MF20] antibody to identify an SGCB splice-site mutation linked to dilated cardiomyopathy.
📄 tinyurl.com/2hdyfkys
🧫 dshb.biology.uiowa.edu/MF-20
Spotted in @braincomms.bsky.social!
Researchers from #CHEO Research Institute, among others, used 4 of DSHB's anti-MHC mAbs to examine how different genetic forms of CMS respond to a MuSK‑targeting antibody.
🔎 Spotted in #AdvancedScience!
Researchers from #NYUGrossman and @dnanexus.bsky.social used our PAX7 antibody in a study mapping FAP signaling in skeletal muscle, revealing how cell populations communicate during homeostasis and regeneration.
📄 tinyurl.com/32k25caf
🧫 dshb.biology.uiowa.edu/PAX7
🔎 Spotted in #AgingCell by #AnatomicalSociety!
Researchers from #UWSeattle and #VAPugetSound used DSHB's anti-β-tubulin [E7] in a study demonstrating how the reduction or loss of the protein SMARCAD1 affects tauopathy in C. elegans.
📄 tinyurl.com/4ypyz3sr
🧫 dshb.biology.uiowa.edu/E7_2